Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1992 1
1993 2
1994 3
1995 6
1996 3
1997 1
1998 1
2008 1
2010 1
2012 1
2013 1
2016 1
2017 1
2019 3
2020 3
2021 1
2022 4
2023 4
2024 1
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean s kazarian (1 results)?
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.
Hutchings M, Mous R, Clausen MR, Johnson P, Linton KM, Chamuleau MED, Lewis DJ, Sureda Balari A, Cunningham D, Oliveri RS, Elliott B, DeMarco D, Azaryan A, Chiu C, Li T, Chen KM, Ahmadi T, Lugtenburg PJ. Hutchings M, et al. Lancet. 2021 Sep 25;398(10306):1157-1169. doi: 10.1016/S0140-6736(21)00889-8. Epub 2021 Sep 8. Lancet. 2021. PMID: 34508654 Clinical Trial.
Rationale and design of the ESC Heart Failure III Registry - Implementation and discovery.
Lund LH, Crespo-Leiro MG, Laroche C, Garcia-Pinilla JM, Bennis A, Vataman EB, Polovina M, Radovanovic S, Apostolovic SR, Ašanin M, Gackowski A, Kaplon-Cieslicka A, Cabac-Pogorevici I, Anker SD, Chioncel O, Coats AJS, Filippatos G, Lainscak M, Mcdonagh T, Mebazaa A, Metra M, Piepoli M, Rosano GM, Ruschitzka F, Savarese G, Seferović PM, Iung B, Popescu BA, Maggioni AP; ESC EORP HF III National Leaders and Investigators. Lund LH, et al. Eur J Heart Fail. 2023 Dec;25(12):2316-2330. doi: 10.1002/ejhf.3087. Epub 2023 Nov 29. Eur J Heart Fail. 2023. PMID: 37990135 Free article.
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology.
Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP; NSTEMI investigator group. Nadarajah R, et al. Eur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):552-563. doi: 10.1093/ehjqcco/qcad008. Eur Heart J Qual Care Clin Outcomes. 2023. PMID: 36737420 Free PMC article.
Stimulation of "prohormone thiol protease" (PTP) and [Met]enkephalin by forskolin. Blockade of elevated [Met]enkephalin by a cysteine protease inhibitor of PTP.
Tezapsidis N, Noctor S, Kannan R, Krieger TJ, Mende-Mueller L, Hook VY. Tezapsidis N, et al. J Biol Chem. 1995 Jun 2;270(22):13285-90. doi: 10.1074/jbc.270.22.13285. J Biol Chem. 1995. PMID: 7768928 Free article.
Both E-64c and Ep453 inhibit PTP, with E-64c being more potent (Azaryan, A. V., and Hook, V. Y. H. (1994b) Arch. Biochem. Biophys. 314, 171-177). These results demonstrate a role for PTP in proenkephalin processing in chromaffin cells and indicate that [Met] enkephalin for …
Both E-64c and Ep453 inhibit PTP, with E-64c being more potent (Azaryan, A. V., and Hook, V. Y. H. (1994b) Arch. Biochem. Biophys. 31 …
"Prohormone thiol protease" (PTP) processing of recombinant proenkephalin.
Schiller MR, Mende-Mueller L, Moran K, Meng M, Miller KW, Hook VY. Schiller MR, et al. Biochemistry. 1995 Jun 27;34(25):7988-95. doi: 10.1021/bi00025a004. Biochemistry. 1995. PMID: 7794912
J., Mende-Mueller, L., & Hook, V. Y. H. (1992) J. Neurochem. 59, 26-31; Azaryan, A. V., & Hook, V. Y. H. (1994) FEBS Lett. 341, 197-202]. In this report, PTP processing of authentic proenkephalin (PE) was examined with respect to production of appropriate intermedi …
J., Mende-Mueller, L., & Hook, V. Y. H. (1992) J. Neurochem. 59, 26-31; Azaryan, A. V., & Hook, V. Y. H. (1994) FEBS Lett. 34 …
Effect of PCL/nHAEA nanocomposite to osteo/odontogenic differentiation of dental pulp stem cells.
Azaryan E, Hanafi-Bojd MY, Alemzadeh E, Emadian Razavi F, Naseri M. Azaryan E, et al. BMC Oral Health. 2022 Nov 16;22(1):505. doi: 10.1186/s12903-022-02527-1. BMC Oral Health. 2022. PMID: 36384581 Free PMC article.
Osteo/odontogenic differentiation ability of the nanocomposites were assessed using alkaline phosphatase (ALP) activity, alizarin red S (ARS) staining, and quantitative real-time polymerase chain reaction (qPCR) technique. ...
Osteo/odontogenic differentiation ability of the nanocomposites were assessed using alkaline phosphatase (ALP) activity, alizarin red S …
Nanofibers for paclitaxel delivery: A promising avenue for cancer therapy.
Noori A, Salehi Namini M, Azaryan E, Ataei M, Beheshtizadeh N. Noori A, et al. Biomed Pharmacother. 2025 Nov;192:118607. doi: 10.1016/j.biopha.2025.118607. Epub 2025 Sep 27. Biomed Pharmacother. 2025. PMID: 41014874 Free article. Review.
Additionally, we discuss the therapeutic efficacy of PTX-loaded nanofibers in treating various cancers, highlighting innovative strategies to enhance PTX's anticancer effects. Special attention is given to the integration of nanofibers with complementary therapies, such as …
Additionally, we discuss the therapeutic efficacy of PTX-loaded nanofibers in treating various cancers, highlighting innovative strategies t …
40 results